Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Return on Capital Employed (2019 - 2025)

aTYR PHARMA's Return on Capital Employed history spans 7 years, with the latest figure at 0.92% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 6.0% year-over-year to 0.92%; the TTM value through Dec 2025 reached 0.92%, down 6.0%, while the annual FY2025 figure was 0.97%, 25.0% down from the prior year.
  • Return on Capital Employed reached 0.92% in Q4 2025 per ATYR's latest filing, down from 0.89% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.3% in Q4 2021 to a low of 0.92% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 0.6%, with a median of 0.57% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: increased 21bps in 2022, then plummeted -40bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.3% in 2021, then crashed by -89bps to 0.57% in 2022, then increased by 9bps to 0.52% in 2023, then tumbled by -66bps to 0.86% in 2024, then fell by -7bps to 0.92% in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Return on Capital Employed are 0.92% (Q4 2025), 0.89% (Q3 2025), and 0.84% (Q2 2025).